| |
TTD
Drug ID:
DAP001201
| Drug
Information |
| Name | Sulfacytine | | Synonyms | NSC356717; Sulfacitina; 4-amino-N-(1-ethyl-2-oxopyrimidin-4-yl)benzenesulfonamide; 1-Ethyl N4-sulfanilylcytosin; sulfacytine; Sulfacitina [INN-Spanish]; 1401-49-6; Renoquid (TN); 4-amino-N-(1-ethyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzenesulfonamide; Sulfanilamide, N1-(1-ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- (8CI); Sulfanilamide, N(1)-(1-ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-; AC1Q6C6O; HSDB 3272; CHEMBL1201056; Sulfacitinum; CI-636; D02519; N(sup1)-(1-Ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)sulfanilamide; CL 636; LS-173691; CID5322; Sulfacitinum [INN-Latin]; DB01298; Nl-sulfanilyl-1-ethylcytosine; Sulfacytine [USAN:BAN]; Sulfacitine; N(sup 1)-(1-Ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)sulfanilamide; Sulfanilamide, N1-(1-ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-; UNII-T795873AJP; Renoquid; Benzenesulfonamide, 4-amino-N-(1-ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-; AR-1L5715; NSC 356717; N-Sulfanilyl-l-ethylcytosine; 17784-12-2; CI 636; 1-Ethyl-N-sulfanilylcytosine; AC1L1K3H; Sulfacytine (USAN) | | Indication | Urinary tract infections | Approved [1] | | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format | | Therapeutic Class | Antiinfective Agents | | CAS Number | CAS 17784-12-2 | | Formular | C12H14N4O3S | | PubChem Compound ID | CID 5322. | | PubChem Substance ID | SID 171192. | | Target | Plasmodium falciparum Dihydropteroate synthetase |  | Inhibitor | [2] | | Ref 1 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 017569 To Reference | | Ref 2 | Sulfacytine in uncomplicated urinary tract infections. Double-blind comparison with sulfisoxazole. Urology. 1976 Mar;7(3):267-71. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|
|